83.83 USD
-1.17 (-1.38%)
83.83 USD
0 (0%)
Taking everything into account, LMAT scores 7 out of 10 in our fundamental rating. LMAT was compared to 185 industry peers in the Health Care Equipment & Supplies industry. LMAT scores excellent points on both the profitability and health parts. This is a solid base for a good stock. LMAT has a decent growth rate and is not valued too expensively. With these ratings, LMAT could be worth investigating further for quality investing!.
1. Profitability
1.1 Basic Checks
In the past year LMAT was profitable.
In the past year LMAT had a positive cash flow from operations.
LMAT had positive earnings in each of the past 5 years.
LMAT had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
LMAT's Return On Assets of 8.92% is amongst the best of the industry. LMAT outperforms 91.35% of its industry peers.
With an excellent Return On Equity value of 14.08%, LMAT belongs to the best of the industry, outperforming 90.27% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 8.43%, LMAT belongs to the top of the industry, outperforming 87.03% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for LMAT is in line with the industry average of 8.84%.
The 3 year average ROIC (8.26%) for LMAT is below the current ROIC(8.43%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.92% | ||
| ROE | 14.08% | ||
| ROIC | 8.43% |
ROA(3y)7.77%
ROA(5y)8.17%
ROE(3y)10.28%
ROE(5y)10.74%
ROIC(3y)8.26%
ROIC(5y)8.93%
1.3 Margins
With an excellent Profit Margin value of 22.14%, LMAT belongs to the best of the industry, outperforming 94.05% of the companies in the same industry.
LMAT's Profit Margin has improved in the last couple of years.
LMAT has a better Operating Margin (25.71%) than 95.14% of its industry peers.
In the last couple of years the Operating Margin of LMAT has grown nicely.
The Gross Margin of LMAT (70.97%) is better than 79.46% of its industry peers.
In the last couple of years the Gross Margin of LMAT has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 25.71% | ||
| PM (TTM) | 22.14% | ||
| GM | 70.97% |
OM growth 3Y0.27%
OM growth 5Y5.61%
PM growth 3Y4.76%
PM growth 5Y5.57%
GM growth 3Y1.48%
GM growth 5Y0.13%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so LMAT is destroying value.
LMAT has more shares outstanding than it did 1 year ago.
LMAT has more shares outstanding than it did 5 years ago.
LMAT has a worse debt/assets ratio than last year.
2.2 Solvency
LMAT has an Altman-Z score of 7.20. This indicates that LMAT is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 7.20, LMAT belongs to the best of the industry, outperforming 84.32% of the companies in the same industry.
LMAT has a debt to FCF ratio of 2.54. This is a good value and a sign of high solvency as LMAT would need 2.54 years to pay back of all of its debts.
LMAT's Debt to FCF ratio of 2.54 is amongst the best of the industry. LMAT outperforms 84.86% of its industry peers.
A Debt/Equity ratio of 0.44 indicates that LMAT is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.44, LMAT is in line with its industry, outperforming 45.41% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.44 | ||
| Debt/FCF | 2.54 | ||
| Altman-Z | 7.2 |
ROIC/WACC0.85
WACC9.87%
2.3 Liquidity
A Current Ratio of 13.58 indicates that LMAT has no problem at all paying its short term obligations.
LMAT's Current ratio of 13.58 is amongst the best of the industry. LMAT outperforms 97.84% of its industry peers.
LMAT has a Quick Ratio of 11.45. This indicates that LMAT is financially healthy and has no problem in meeting its short term obligations.
LMAT has a better Quick ratio (11.45) than 95.68% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 13.58 | ||
| Quick Ratio | 11.45 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an nice 19.67% over the past year.
LMAT shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 17.13% yearly.
LMAT shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 13.07%.
LMAT shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 13.41% yearly.
EPS 1Y (TTM)19.67%
EPS 3Y15.47%
EPS 5Y17.13%
EPS Q2Q%26.53%
Revenue 1Y (TTM)13.07%
Revenue growth 3Y12.5%
Revenue growth 5Y13.41%
Sales Q2Q%11.36%
3.2 Future
The Earnings Per Share is expected to grow by 11.10% on average over the next years. This is quite good.
The Revenue is expected to grow by 9.65% on average over the next years. This is quite good.
EPS Next Y27.49%
EPS Next 2Y16.63%
EPS Next 3Y14.06%
EPS Next 5Y11.1%
Revenue Next Year12.78%
Revenue Next 2Y10.91%
Revenue Next 3Y10.19%
Revenue Next 5Y9.65%
3.3 Evolution
The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 38.28, LMAT can be considered very expensive at the moment.
71.35% of the companies in the same industry are more expensive than LMAT, based on the Price/Earnings ratio.
Compared to an average S&P500 Price/Earnings ratio of 27.25, LMAT is valued a bit more expensive.
LMAT is valuated quite expensively with a Price/Forward Earnings ratio of 31.77.
Based on the Price/Forward Earnings ratio, LMAT is valued a bit cheaper than 72.43% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of LMAT to the average of the S&P500 Index (23.98), we can say LMAT is valued slightly more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 38.28 | ||
| Fwd PE | 31.77 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, LMAT is valued a bit cheaper than 77.30% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of LMAT indicates a rather cheap valuation: LMAT is cheaper than 81.08% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 28.72 | ||
| EV/EBITDA | 19.52 |
4.3 Compensation for Growth
LMAT's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
The excellent profitability rating of LMAT may justify a higher PE ratio.
LMAT's earnings are expected to grow with 14.06% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.39
PEG (5Y)2.23
EPS Next 2Y16.63%
EPS Next 3Y14.06%
5. Dividend
5.1 Amount
LMAT has a yearly dividend return of 0.94%, which is pretty low.
Compared to an average industry Dividend Yield of 0.19, LMAT pays a better dividend. On top of this LMAT pays more dividend than 91.89% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 1.92, LMAT's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.94% |
5.2 History
The dividend of LMAT is nicely growing with an annual growth rate of 13.60%!
LMAT has been paying a dividend for at least 10 years, so it has a reliable track record.
LMAT has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)13.6%
Div Incr Years13
Div Non Decr Years13
5.3 Sustainability
LMAT pays out 32.20% of its income as dividend. This is a sustainable payout ratio.
LMAT's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP32.2%
EPS Next 2Y16.63%
EPS Next 3Y14.06%
83.83
-1.17 (-1.38%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners95.2%
Inst Owner Change4.08%
Ins Owners7.98%
Ins Owner Change-4.67%
Market Cap1.90B
Revenue(TTM)240.87M
Net Income(TTM)53.34M
Analysts78.82
Price Target105.74 (26.14%)
Short Float %5.41%
Short Ratio6.52
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.94% |
Yearly Dividend0.64
Dividend Growth(5Y)13.6%
DP32.2%
Div Incr Years13
Div Non Decr Years13
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)5.59%
Min EPS beat(2)3.81%
Max EPS beat(2)7.38%
EPS beat(4)2
Avg EPS beat(4)0.79%
Min EPS beat(4)-5.52%
Max EPS beat(4)7.38%
EPS beat(8)6
Avg EPS beat(8)4.68%
EPS beat(12)9
Avg EPS beat(12)4.66%
EPS beat(16)9
Avg EPS beat(16)-0.71%
Revenue beat(2)1
Avg Revenue beat(2)-1.47%
Min Revenue beat(2)-3.74%
Max Revenue beat(2)0.79%
Revenue beat(4)2
Avg Revenue beat(4)-0.88%
Min Revenue beat(4)-3.74%
Max Revenue beat(4)1.83%
Revenue beat(8)4
Avg Revenue beat(8)-0.49%
Revenue beat(12)6
Avg Revenue beat(12)-0.01%
Revenue beat(16)7
Avg Revenue beat(16)-0.44%
PT rev (1m)-0.64%
PT rev (3m)-1.06%
EPS NQ rev (1m)0%
EPS NQ rev (3m)4.07%
EPS NY rev (1m)-0.19%
EPS NY rev (3m)6.22%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-2.16%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.94%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 38.28 | ||
| Fwd PE | 31.77 | ||
| P/S | 7.9 | ||
| P/FCF | 28.72 | ||
| P/OCF | 25.96 | ||
| P/B | 5.02 | ||
| P/tB | 6.76 | ||
| EV/EBITDA | 19.52 |
EPS(TTM)2.19
EY2.61%
EPS(NY)2.64
Fwd EY3.15%
FCF(TTM)2.92
FCFY3.48%
OCF(TTM)3.23
OCFY3.85%
SpS10.62
BVpS16.7
TBVpS12.4
PEG (NY)1.39
PEG (5Y)2.23
Graham Number28.69
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.92% | ||
| ROE | 14.08% | ||
| ROCE | 10.97% | ||
| ROIC | 8.43% | ||
| ROICexc | 21.47% | ||
| ROICexgc | 38.36% | ||
| OM | 25.71% | ||
| PM (TTM) | 22.14% | ||
| GM | 70.97% | ||
| FCFM | 27.5% |
ROA(3y)7.77%
ROA(5y)8.17%
ROE(3y)10.28%
ROE(5y)10.74%
ROIC(3y)8.26%
ROIC(5y)8.93%
ROICexc(3y)14.32%
ROICexc(5y)13.54%
ROICexgc(3y)28.83%
ROICexgc(5y)29.82%
ROCE(3y)10.75%
ROCE(5y)11.62%
ROICexgc growth 3Y-0.4%
ROICexgc growth 5Y7.52%
ROICexc growth 3Y9.22%
ROICexc growth 5Y8.43%
OM growth 3Y0.27%
OM growth 5Y5.61%
PM growth 3Y4.76%
PM growth 5Y5.57%
GM growth 3Y1.48%
GM growth 5Y0.13%
F-Score5
Asset Turnover0.4
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.44 | ||
| Debt/FCF | 2.54 | ||
| Debt/EBITDA | 2.33 | ||
| Cap/Depr | 68.51% | ||
| Cap/Sales | 2.93% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 101.46% | ||
| Profit Quality | 124.17% | ||
| Current Ratio | 13.58 | ||
| Quick Ratio | 11.45 | ||
| Altman-Z | 7.2 |
F-Score5
WACC9.87%
ROIC/WACC0.85
Cap/Depr(3y)60.87%
Cap/Depr(5y)52.43%
Cap/Sales(3y)2.97%
Cap/Sales(5y)2.88%
Profit Quality(3y)96.62%
Profit Quality(5y)110.46%
High Growth Momentum
Growth
EPS 1Y (TTM)19.67%
EPS 3Y15.47%
EPS 5Y17.13%
EPS Q2Q%26.53%
EPS Next Y27.49%
EPS Next 2Y16.63%
EPS Next 3Y14.06%
EPS Next 5Y11.1%
Revenue 1Y (TTM)13.07%
Revenue growth 3Y12.5%
Revenue growth 5Y13.41%
Sales Q2Q%11.36%
Revenue Next Year12.78%
Revenue Next 2Y10.91%
Revenue Next 3Y10.19%
Revenue Next 5Y9.65%
EBIT growth 1Y24.85%
EBIT growth 3Y12.81%
EBIT growth 5Y19.77%
EBIT Next Year45.26%
EBIT Next 3Y22.27%
EBIT Next 5YN/A
FCF growth 1Y189.96%
FCF growth 3Y7.14%
FCF growth 5Y28.96%
OCF growth 1Y143.52%
OCF growth 3Y7.93%
OCF growth 5Y25.49%
LEMAITRE VASCULAR INC / LMAT FAQ
What is the ChartMill fundamental rating of LEMAITRE VASCULAR INC (LMAT) stock?
ChartMill assigns a fundamental rating of 7 / 10 to LMAT.
What is the valuation status of LEMAITRE VASCULAR INC (LMAT) stock?
ChartMill assigns a valuation rating of 5 / 10 to LEMAITRE VASCULAR INC (LMAT). This can be considered as Fairly Valued.
How profitable is LEMAITRE VASCULAR INC (LMAT) stock?
LEMAITRE VASCULAR INC (LMAT) has a profitability rating of 9 / 10.
What is the valuation of LEMAITRE VASCULAR INC based on its PE and PB ratios?
The Price/Earnings (PE) ratio for LEMAITRE VASCULAR INC (LMAT) is 38.28 and the Price/Book (PB) ratio is 5.02.
How financially healthy is LEMAITRE VASCULAR INC?
The financial health rating of LEMAITRE VASCULAR INC (LMAT) is 7 / 10.